Skip to content
About Us
Corporate Profile
Senior Management
Board of Directors
Advisors and EDBI Connect
Core Values
Careers
Why EDBI
Why EDBI
Impact
Value Creation
Focal Sectors
Focal Sectors
Investment Criteria
Portfolio
News
Contact Us
Menu
About Us
Corporate Profile
Senior Management
Board of Directors
Advisors and EDBI Connect
Core Values
Careers
Why EDBI
Why EDBI
Impact
Value Creation
Focal Sectors
Focal Sectors
Investment Criteria
Portfolio
News
Contact Us
Menu
About Us
Corporate Profile
Senior Management
Board of Directors
Advisors and EDBI Connect
Core Values
Careers
Why EDBI
Why EDBI
Impact
Value Creation
Focal Sectors
Focal Sectors
Investment Criteria
Portfolio
News
Contact Us
Contact us
Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda
15 May 2012
Share on facebook
Share on twitter
Share on linkedin
ADAMAS PHARMACEUTICALS ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING WITH FDA FOR ARIMENDATM